Clinical Trial Update: High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating high-dose inorganic selenium for preventing chemotherapy-induced peripheral neuropathy in ovarian cancer patients is in the early/unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Carcinoma

Drugs mentioned

• High Dose Inorganic Selenium (selenium)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Chemotherapy-induced Peripheral Neuropathy, Recurrent Ovarian Carcinoma | Phase 3 | Status: UNKNOWN